BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 29101022)

  • 1. LSD modulates effective connectivity and neural adaptation mechanisms in an auditory oddball paradigm.
    Timmermann C; Spriggs MJ; Kaelen M; Leech R; Nutt DJ; Moran RJ; Carhart-Harris RL; Muthukumaraswamy SD
    Neuropharmacology; 2018 Nov; 142():251-262. PubMed ID: 29101022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LSD modulates music-induced imagery via changes in parahippocampal connectivity.
    Kaelen M; Roseman L; Kahan J; Santos-Ribeiro A; Orban C; Lorenz R; Barrett FS; Bolstridge M; Williams T; Williams L; Wall MB; Feilding A; Muthukumaraswamy S; Nutt DJ; Carhart-Harris R
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1099-109. PubMed ID: 27084302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective connectivity changes in LSD-induced altered states of consciousness in humans.
    Preller KH; Razi A; Zeidman P; Stämpfli P; Friston KJ; Vollenweider FX
    Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2743-2748. PubMed ID: 30692255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural correlates of the LSD experience revealed by multimodal neuroimaging.
    Carhart-Harris RL; Muthukumaraswamy S; Roseman L; Kaelen M; Droog W; Murphy K; Tagliazucchi E; Schenberg EE; Nest T; Orban C; Leech R; Williams LT; Williams TM; Bolstridge M; Sessa B; McGonigle J; Sereno MI; Nichols D; Hellyer PJ; Hobden P; Evans J; Singh KD; Wise RG; Curran HV; Feilding A; Nutt DJ
    Proc Natl Acad Sci U S A; 2016 Apr; 113(17):4853-8. PubMed ID: 27071089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution.
    Tagliazucchi E; Roseman L; Kaelen M; Orban C; Muthukumaraswamy SD; Murphy K; Laufs H; Leech R; McGonigle J; Crossley N; Bullmore E; Williams T; Bolstridge M; Feilding A; Nutt DJ; Carhart-Harris R
    Curr Biol; 2016 Apr; 26(8):1043-50. PubMed ID: 27085214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor.
    Preller KH; Burt JB; Ji JL; Schleifer CH; Adkinson BD; Stämpfli P; Seifritz E; Repovs G; Krystal JH; Murray JD; Vollenweider FX; Anticevic A
    Elife; 2018 Oct; 7():. PubMed ID: 30355445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LSD alters dynamic integration and segregation in the human brain.
    Luppi AI; Carhart-Harris RL; Roseman L; Pappas I; Menon DK; Stamatakis EA
    Neuroimage; 2021 Feb; 227():117653. PubMed ID: 33338615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin.
    Schartner MM; Carhart-Harris RL; Barrett AB; Seth AK; Muthukumaraswamy SD
    Sci Rep; 2017 Apr; 7():46421. PubMed ID: 28422113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased directed functional connectivity in the psychedelic state.
    Barnett L; Muthukumaraswamy SD; Carhart-Harris RL; Seth AK
    Neuroimage; 2020 Apr; 209():116462. PubMed ID: 31857204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective Connectivity of Functionally Anticorrelated Networks Under Lysergic Acid Diethylamide.
    Stoliker D; Novelli L; Vollenweider FX; Egan GF; Preller KH; Razi A
    Biol Psychiatry; 2023 Feb; 93(3):224-232. PubMed ID: 36270812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity.
    Bedford P; Hauke DJ; Wang Z; Roth V; Nagy-Huber M; Holze F; Ley L; Vizeli P; Liechti ME; Borgwardt S; Müller F; Diaconescu AO
    Neuropsychopharmacology; 2023 Jul; 48(8):1175-1183. PubMed ID: 37185950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the 5-HT
    Preller KH; Schilbach L; Pokorny T; Flemming J; Seifritz E; Vollenweider FX
    J Neurosci; 2018 Apr; 38(14):3603-3611. PubMed ID: 29555857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults.
    Murray CH; Tare I; Perry CM; Malina M; Lee R; de Wit H
    Psychopharmacology (Berl); 2022 Jun; 239(6):1735-1747. PubMed ID: 34613430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin 2A Receptor Signaling Underlies LSD-induced Alteration of the Neural Response to Dynamic Changes in Music.
    Barrett FS; Preller KH; Herdener M; Janata P; Vollenweider FX
    Cereb Cortex; 2018 Nov; 28(11):3939-3950. PubMed ID: 29028939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion.
    Roseman L; Sereno MI; Leech R; Kaelen M; Orban C; McGonigle J; Feilding A; Nutt DJ; Carhart-Harris RL
    Hum Brain Mapp; 2016 Aug; 37(8):3031-40. PubMed ID: 27125770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains.
    Varley TF; Carhart-Harris R; Roseman L; Menon DK; Stamatakis EA
    Neuroimage; 2020 Oct; 220():117049. PubMed ID: 32619708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered network hub connectivity after acute LSD administration.
    Müller F; Dolder PC; Schmidt A; Liechti ME; Borgwardt S
    Neuroimage Clin; 2018; 18():694-701. PubMed ID: 29560311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice.
    Inserra A; De Gregorio D; Rezai T; Lopez-Canul MG; Comai S; Gobbi G
    J Psychopharmacol; 2021 Apr; 35(4):469-482. PubMed ID: 33645311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing Thalamocortical (Dys)connectivity Following D-Amphetamine, LSD, and MDMA Administration.
    Avram M; Müller F; Rogg H; Korda A; Andreou C; Holze F; Vizeli P; Ley L; Liechti ME; Borgwardt S
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Sep; 7(9):885-894. PubMed ID: 35500840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychedelics: Where we are now, why we got here, what we must do.
    Belouin SJ; Henningfield JE
    Neuropharmacology; 2018 Nov; 142():7-19. PubMed ID: 29476779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.